Patent · US Active

Heteroaryl inhibitors of PDE4

US10093686B2 · kind B2 · utility

5Cited by

3References

34Claims

0Family size

Assignee

Tetra Discovery Partners · US

Inventors

Mark E. Gurney · Grand Rapids, US
Timothy J. Hagen · Gurnee, US
Xuesheng Mo · Naperville, US
A. Samuel Vellekoop · Altamont, US
Donna L. Romero · Chesterfield, US
Robert Campbell · Niskayuna, US
Joel R. Walker · Tucson, US
Lei Zhu · Hefei, CN

Key dates

Filing date	Aug 18, 2017
Grant date	Oct 9, 2018
Priority date	—
Expiry date	Aug 18, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F5/025
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.